In her career, Audrey has been successful at design and implementation of new concepts and programs in both research and clinical areas. Previously, as supervisor of the Clinical Molecular Pathology Laboratory in the Department of Pathology at The Ohio State University Medical Center, she played a key role in developing the test portfolio, and establishing the Molecular Pathology Laboratory as a CLIA certified lab. In addition to participation in both clinical and research aspects of health care, she is a contributing author on over 80 papers. Audrey has been a featured speaker, and workshop leader at national conferences, webcasts and other events. One of her most recent projects was to create a new OSU graduate course: Personalized Therapeutics and Pharmacogenomics, a 3 credit online class in the new OSU Master's Program in Translational Pharmacology. Audrey is currently working on a pilot project with the Bill and Melinda Gates Foundation to develop better tuberculosis vaccines using targeted transcriptome sequencing and functional genetic variant analysis.